Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AJU Pharmaceutical is a South Korean commercial-stage pharmaceutical company founded in 1953 that manufactures and markets prescription medicines, contract-manufactured pharmaceutical products, medical devices, and consumer health products. The company has a long operating history in anti-infectives and chronic-disease medicines, with marketed portfolios spanning cardiovascular, endocrine, gastrointestinal, urology, musculoskeletal, respiratory, ophthalmology, and other therapeutic categories. AJU also operates a GMP manufacturing site in Pyeongtaek and offers CMO services alongside product development, export, and lifecycle management capabilities. Its business appears focused on branded generics, in-licensed products, value-added formulations, and selected new product development rather than a classic venture-style innovative biotech pipeline. Following a 2025 governance restructuring, AJU Pharmaceutical operates within AJU Holdings alongside related healthcare subsidiaries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AJU Pharmaceutical.